Medtide Inc., CPC Scientific’s Parent Company, Debuts on Hong Kong Stock Exchange
Honoring how far we’ve come and where we’re headed
Join us as we celebrate a proud milestone: the successful listing of Medtide Inc., parent company of CPC Scientific, on the main board of the Hong Kong Stock Exchange in June 2025. This moment marks a new chapter of growth, innovation, and global impact for our organization.
To learn more about Medtide Inc: https://www.medtideinc.com/
📍 Location: Hong Kong
📅 Date: June 30, 2025
Timestamps:
00:00 – Introduction
00:32 – Speech by Vickie Xu, PhD (Chairwoman and Executive Director of Medtide Inc.)
00:55 – Closing Highlights / Ceremony Ending
Don’t hesitate to reach out to us for a consultation or contact us at [email protected]. We’d love to support your peptide and oligonucleotide projects!
About MEDTIDE INC.
MEDTIDE INC. is a Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in peptides. The Company provides end-to-end services from early discovery and preclinical research to clinical development and commercial manufacturing. Headquartered in Hangzhou, China, the Company operates commercial manufacturing sites and offices in both China and the United States.
With over 20 years of experience in the peptide field, MEDTIDE INC. is a globally integrated CRDMO with comprehensive service capabilities. Our CRDMO services cover the full pharmaceutical development lifecycle, including:
- CRO services – Discovery and synthesis of novel peptide chemical entities (NCEs);
- CDMO services – Peptide Chemistry, Manufacturing, and Controls (CMC) development and commercial production.
To date, we have served over 1,000 clients across more than 50 countries, including major markets such as China, the United States, Japan, Europe, South Korea, and Australia, providing peptide drug synthesis, development, production, and regulatory CMC support in compliance with global standards.
As a trusted and steadily growing partner, MEDTIDE INC. has established long-term collaborations with many clients. Through close partnerships, we help bring life-changing therapies to market—always placing patients at the center and advancing global human health.
